Intercontinental Exchange, Inc. (BMV:ICE)
Mexico · Delayed Price · Currency is MXN 3,509.55
0.00 (0.00%)
At close: Aug 7, 2025, 2:00 PM CST
Ligand Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 9,688 | 9,279 | 7,988 | 7,292 | 7,146 | 6,036 | Upgrade |
| 9,688 | 9,279 | 7,988 | 7,292 | 7,146 | 6,036 | Upgrade | |
Revenue Growth (YoY) | 9.95% | 16.16% | 9.54% | 2.04% | 18.39% | 16.03% | Upgrade |
Gross Profit | 9,688 | 9,279 | 7,988 | 7,292 | 7,146 | 6,036 | Upgrade |
Selling, General & Admin | 3,327 | 3,320 | 2,808 | 2,530 | 2,586 | 2,147 | Upgrade |
Operating Expenses | 4,886 | 4,854 | 4,016 | 3,561 | 3,595 | 2,898 | Upgrade |
Operating Income | 4,802 | 4,425 | 3,972 | 3,731 | 3,551 | 3,138 | Upgrade |
Interest Expense | -843 | -910 | -808 | -616 | -423 | -357 | Upgrade |
Interest & Investment Income | 139 | 141 | 319 | 108 | 1 | 10 | Upgrade |
Earnings From Equity Investments | 20 | -62 | -122 | - | - | 71 | Upgrade |
Currency Exchange Gain (Loss) | -21 | -15 | -12 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 2 | 1 | -16 | -1,322 | 2,671 | -26 | Upgrade |
EBT Excluding Unusual Items | 4,099 | 3,580 | 3,333 | 1,901 | 5,800 | 2,836 | Upgrade |
Merger & Restructuring Charges | -95 | -104 | -269 | -93 | -102 | -105 | Upgrade |
Gain (Loss) on Sale of Investments | 2 | -1 | -3 | - | - | 35 | Upgrade |
Gain (Loss) on Sale of Assets | 6 | 6 | - | - | - | - | Upgrade |
Asset Writedown | - | -3 | -7 | - | - | - | Upgrade |
Legal Settlements | - | 160 | - | - | - | - | Upgrade |
Other Unusual Items | -30 | -30 | -160 | - | - | - | Upgrade |
Pretax Income | 4,002 | 3,628 | 2,894 | 1,808 | 5,698 | 2,766 | Upgrade |
Income Tax Expense | 945 | 826 | 456 | 310 | 1,629 | 658 | Upgrade |
Earnings From Continuing Operations | 3,057 | 2,802 | 2,438 | 1,498 | 4,069 | 2,108 | Upgrade |
Net Income to Company | 3,057 | 2,802 | 2,438 | 1,498 | 4,069 | 2,108 | Upgrade |
Minority Interest in Earnings | -54 | -48 | -70 | -52 | -11 | -19 | Upgrade |
Net Income | 3,003 | 2,754 | 2,368 | 1,446 | 4,058 | 2,089 | Upgrade |
Net Income to Common | 3,003 | 2,754 | 2,368 | 1,446 | 4,058 | 2,089 | Upgrade |
Net Income Growth | 29.83% | 16.30% | 63.76% | -64.37% | 94.26% | 8.07% | Upgrade |
Shares Outstanding (Basic) | 574 | 573 | 564 | 559 | 562 | 552 | Upgrade |
Shares Outstanding (Diluted) | 577 | 576 | 565 | 561 | 565 | 555 | Upgrade |
Shares Change (YoY) | 0.79% | 1.95% | 0.71% | -0.71% | 1.80% | -1.77% | Upgrade |
EPS (Basic) | 5.24 | 4.81 | 4.20 | 2.59 | 7.22 | 3.78 | Upgrade |
EPS (Diluted) | 5.21 | 4.78 | 4.19 | 2.58 | 7.18 | 3.77 | Upgrade |
EPS Growth | 28.91% | 14.08% | 62.40% | -64.07% | 90.45% | 10.23% | Upgrade |
Free Cash Flow | 4,458 | 4,203 | 3,352 | 3,329 | 2,944 | 2,674 | Upgrade |
Free Cash Flow Per Share | 7.73 | 7.30 | 5.93 | 5.93 | 5.21 | 4.82 | Upgrade |
Dividend Per Share | 1.860 | 1.800 | 1.680 | 1.520 | 1.320 | 1.200 | Upgrade |
Dividend Growth | 6.90% | 7.14% | 10.53% | 15.15% | 10.00% | 9.09% | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 49.57% | 47.69% | 49.73% | 51.17% | 49.69% | 51.99% | Upgrade |
Profit Margin | 31.00% | 29.68% | 29.64% | 19.83% | 56.79% | 34.61% | Upgrade |
Free Cash Flow Margin | 46.02% | 45.30% | 41.96% | 45.65% | 41.20% | 44.30% | Upgrade |
EBITDA | 6,037 | 5,635 | 4,896 | 4,515 | 4,347 | 3,699 | Upgrade |
EBITDA Margin | 62.31% | 60.73% | 61.29% | 61.92% | 60.83% | 61.28% | Upgrade |
D&A For EBITDA | 1,235 | 1,210 | 924 | 784 | 796 | 561 | Upgrade |
EBIT | 4,802 | 4,425 | 3,972 | 3,731 | 3,551 | 3,138 | Upgrade |
EBIT Margin | 49.57% | 47.69% | 49.73% | 51.17% | 49.69% | 51.99% | Upgrade |
Effective Tax Rate | 23.61% | 22.77% | 15.76% | 17.15% | 28.59% | 23.79% | Upgrade |
Revenue as Reported | 9,688 | 9,279 | 7,988 | 7,292 | 7,146 | 6,036 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.